| 李康之
，占振瀛
，魏路华
，王朝霞
，赵亚雯.腹壁舞蹈症：中国首例报道并系统评价[J].神经损伤功能重建,2023,(知网首发): |
| 腹壁舞蹈症：中国首例报道并系统评价 |
| Belly Dancer’s Syndrome: The First Case Report in China and Systematic Review |
| |
| DOI： |
| 中文关键词: 腹壁舞蹈症 节段性肌张力障碍 系统评价 |
| 英文关键词: Belly Dancer’s Syndrome segmental dystonia systematic review |
| 基金项目:北大医学青年科技
创新培育基金资助
项目（No. BMU202
0PYB012） |
|
| 摘要点击次数: 192 |
| 全文下载次数: 257 |
| 中文摘要: |
| 目的：通过报道中国首例腹壁舞蹈症患者的临床特征并结合系统评价分析，加深临床对腹壁舞蹈症
这一少见综合征的了解。方法：本研究报道中国首例腹壁舞蹈症患者的临床特征；按照 PRISMA 协议对目
前所报道的腹壁舞蹈症病例进行系统评价。结果：33篇符合相关纳入标准的文章被纳入，共纳入44例腹壁
舞蹈症患者。发病诱因或病因方面，腹部手术为最多见的诱因。患者腹部主要表现为缓慢运动、快速运动、
阵挛样运动及其不同运动形式的组合，多数患者症状表现为渐进性加重。在治疗方面，对于存在可去除诱
因的患者，去除诱因后症状可显著缓解。药物治疗方面，GABA能药物、膜离子通道稳定剂、左乙拉西坦相
关药物有效，免疫治疗无效。药物治疗无效时，局部注射肉毒素、手术治疗可作为可选的治疗方案。结论：
本研究报道了中国首例腹壁舞蹈症患者临床资料，系统评价了腹部舞蹈症临床特征，为临床医师认识这一
少见综合征提供了依据。目的：通过报道中国首例腹壁舞蹈症患者的临床特征并结合系统评价分析，加深临床对腹壁舞蹈症
这一少见综合征的了解。方法：本研究报道中国首例腹壁舞蹈症患者的临床特征；按照 PRISMA 协议对目
前所报道的腹壁舞蹈症病例进行系统评价。结果：33篇符合相关纳入标准的文章被纳入，共纳入44例腹壁
舞蹈症患者。发病诱因或病因方面，腹部手术为最多见的诱因。患者腹部主要表现为缓慢运动、快速运动、
阵挛样运动及其不同运动形式的组合，多数患者症状表现为渐进性加重。在治疗方面，对于存在可去除诱
因的患者，去除诱因后症状可显著缓解。药物治疗方面，GABA能药物、膜离子通道稳定剂、左乙拉西坦相
关药物有效，免疫治疗无效。药物治疗无效时，局部注射肉毒素、手术治疗可作为可选的治疗方案。结论：
本研究报道了中国首例腹壁舞蹈症患者临床资料，系统评价了腹部舞蹈症临床特征，为临床医师认识这一
少见综合征提供了依据。 |
| 英文摘要: |
| To deepen the understanding of Belly dancer’s syndrome, a rare syndrome, by reporting
the clinical features of the first patient with Belly dancer’s syndrome in China and performing a systematic
review. Methods: This study described the clinical features of the first Chinese patients with belly dancer’s
syndrome. A systematic review of the currently reported cases of belly dancer’s syndrome was further
performed according to the PRISMA protocol. Results: Thirty-three articles meeting the inclusion criteria were
included, involving a total of 44 patients with belly dancer’s syndrome. Abdominal surgery was the most
common cause or trigger of the disease. The main manifestations in the abdomen were slow movement, fast
movement, clonic movement, and combinations of different movements. Most patients experienced progressive
worsening of their symptoms. In terms of treatment, for patients with removable triggers, symptoms could
significantly improve after removing the triggers. Regarding medication, GABAergic drugs, membrane ion
channel stabilizers, and levetiracetam-related drugs were effective, while immunotherapy was ineffective. When
medication is ineffective, local injection of botulinum toxin and surgical treatment can be considered as optional
treatment options. Conclusion: This study reported the first case of belly dancer’s syndrome in China and
systematically evaluated the clinical characteristics of this syndrome, providing a basis for clinicians to
understand this rare syndrome. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|